Prophylaxe und Therapie von Atemwegsinfekten mit Echinacea-Extrakten

Zusammenfassung

Atemwegsinfekte sind primär viraler Genese, können aber auch durch Bakterien bedingt sein oder durch bakterielle Superinfektion kompliziert werden. Die unkritische Verordnung von Antibiotika bei viralen Atemwegsinfekten führt zu unerwünschten Wirkungen v.a. im Gastrointestinaltrakt, Allergien, Antibiotikaresistenz und unnötigen Kosten für das Gesundheitssystem. Zahlreiche pflanzliche Arzneimittel stehen zur Therapie akuter Atemwegsinfekte zur Verfügung. Zur Prophylaxe sowie zur Therapie akuter und rezidivierender Atemwegsinfekte geeignet sind Extrakte aus Echinacea purpurea. Echinaforce^®, ein standardisierter, ethanolischer Extrakt aus frischem, blühendem Kraut und den Wurzeln von Echinacea purpurea, wirkt antiviral, antibakteriell und durch Immunmodulation entzündungshemmend. Eine aktuelle Metaanalyse belegt die Verminderung des Risikos von Rezidiven und Komplikationen von Atemwegsinfekten durch Echinacea im Vergleich zu Placebo.

Schlüsselwörter

Echinacea purpurea (L.) Moench - Atemwegserkrankungen - Prophylaxe

Keywords

Echinacea purpurea (L.) Moench - respiratory tract infections - prophylaxis

• Literatur

• 1 Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112: 13-18
• 2 Fahey T, Stocks N, Thomas T. Quantitative systemic review of randomized controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ 1998; 316: 906-910
• 3 Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2014; CD000245
• 4 Risnes KR, Belanger K, Murk W, Bracken MB. Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am J Epidemiol 2011; 173: 310-318
• 5 Nasrin D, Collignon PJ, Roberts L et al. Effect of β lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 2002; 324: 28-30
• 6 Bronzwaer SL, Cars O, Buchholz U et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-282
• 7 WHO. Antimicrobial resistance: global report on surveillance 2014. World Health Organization. URL: http://www.who.int/drugresistance/documents/surveillancereport/en
• 8 Nationale Strategie zur Reduktion von Spital- und Pflegeheiminfektionen (Strategie NOSO). Bundesamt für Gesundheit 2015. URL: https://www.news.admin.ch/message/index.html?lang=de&msg-id=57988
• 9 Persönliche Mitteilung: Prof. Dr. phil. Herbert Hächler, Leiter NENT, Institut für Lebensmittelsicherheit und -hygiene der Universität Zürich http://www.ils.uzh.ch
• 10 Roxas M, Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev 2007; 12: 25-48
• 11 Hudson JB. The use of herbal extracts in the control of influenza. J Med Plant Res 2009; 3: 1189-1195
• 12 Schapowal A. The triple action of the herbal medicine Echinaforce^® in the treatment of colds and flu-like infections. Schweiz Z Ganzheitsmed 2011; 23: 40-44
• 13 Schapowal A. Efficacy and safety of Echinaforce^® in respiratory tract infections. Wien Med Wochenschr 2013; 163: 102-105
• 14 Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res 2009; 83: 165-170
• 15 Pleschka S, Stein M, Schoop R, Hudson JB. Antiviral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virology J 2009; 6: 197
• 16 Sharma S, Anderson SM, Schoop R, Hudson JB. Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce): dual actions against respiratory bacteria. Phytomedicine 2010; 17: 563-568
• 17 Sharma M, Schoop R, Hudson JB. Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters. Phytother Res 2009; 23: 863-867
• 18 Altamirano-Dimas M, Hudson JB, Cochrane D et al. Modulation of immune response gene expression by Echinacea extracts: results of a gene array analysis. Can J Physiol Pharmacol 2007; 85: 1091-1098
• 19 Altamirano-Dimas M, Sharma M, Hudson JB. Echinacea and anti-inflammatory cytokine responses: Results of a gene and protein array analysis. Pharm Biol 2009; 47: 500-508
• 20 Sharma M, Schoop R, Hudson JB. The efficacy of Echinacea in a 3-D tissue model of human airway epithelium. Phytother Res 2010; 24: 900-904
• 21 Ritchie MR, Gertsch J, Klein P et al. Effects of Echinaforce^® treatment on ex vivo-stimulated blood cells. Phytomed 2011; 18: 826-831
• 22 Schoop R, Klein P, Suter A, Johnston SL. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Therapeutics 2006; 28: 174-183
• 23 Shah SA, Sander S, White cm et al. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis 2007; 7: 473-480
• 24 Karsch-Völk M, Barrett B, Kiefer D et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2014; (2): CD000530
• 25 Schapowal A, Klein P, Johnston SL. Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials. Adv Ther 2015; 32: 187-200
• 26 Schmidt U, Albrecht M, Schenk N. Pflanzliches Immunstimulans senkt Häufigkeit grippaler Infekte. Natur- und Ganzheitsmedizin 1990; 3: 277-281
• 27 Grimm W, Muller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of cold and respiratory infections. Am J Med 1999; 106: 138-143
• 28 Melchart D, Walther E, Linde K et al. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch Fam Med 1998; 7: 541-545
• 29 Cohen HA, Varsano I, Kahan E et al. Effectiveness of an herbal preparation containing echinacea, propolis and vitamin c in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, mutlicenter study. Arch Pediatr Adolesc Med 2004; 158: 217-221
• 30 Taylor JA, Weber W, Standish L et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 2003; 290: 2824-2830
• 31 Jawad M, Schoop R, Suter A et al. Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med 2012; 2012: 841315